A study has found that by enhancing the amounts of a marijuana-like brain transmitter, called anandamide, antidepressant effects were produced in test rats.
The study, led by Daniele Piomelli, the Louise Turner Arnold Chair in Neurosciences and director of the Centre for Drug Discovery at the University of California, Irvine, a drug called URB597, created by the researchers, which blocked anandamide degradation in the brain, thereby increasing the levels of this chemical.
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Advertisement
URB597 works by inhibiting FAAH, an enzyme in the body that breaks down anandamide.
Dubbed "the bliss molecule" for its similarities to the active ingredient in marijuana, anandamide is a neurotransmitter that is part of the brain's endocannabinoid system and it has been shown to play analgesic, anti-anxiety and antidepressant roles.
![Anti-depressant Turns Antagonistic at High Doses]( "Anti-depressant Turns Antagonistic at High Doses")
A new study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses. But at higher doses, the effect reverses itself.
In the study, the researchers administered URB597 to chronically stressed rats, which showed behaviours similar to those seen in depressed human patients.
After five weeks of treatment, the stressed rats treated with the drug were behaving similarly to a comparison group of unstressed animals.
Piomelli said that the marijuana could be utilized for treatment of depression.
"These findings raise the hope that the mood-elevating properties of marijuana can be harnessed to treat depression," Piomelli said.
"Marijuana itself has shown no clinical use for depression. However, specific drugs that amplify the actions of natural marijuana-like transmitters in the brain are showing great promise," he added.
The study will be published in Biological Psychiatry.
Source: ANI
SRM/C
Anti-depressant Turns Antagonistic at High Doses
A new study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses. But at higher doses, the effect reverses itself.
Advertisement
In the study, the researchers administered URB597 to chronically stressed rats, which showed behaviours similar to those seen in depressed human patients.
After five weeks of treatment, the stressed rats treated with the drug were behaving similarly to a comparison group of unstressed animals.
Piomelli said that the marijuana could be utilized for treatment of depression.
"These findings raise the hope that the mood-elevating properties of marijuana can be harnessed to treat depression," Piomelli said.
"Marijuana itself has shown no clinical use for depression. However, specific drugs that amplify the actions of natural marijuana-like transmitters in the brain are showing great promise," he added.
The study will be published in Biological Psychiatry.
Source: ANI
SRM/C
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.